LCM Partners has held the final close of the Credit Opportunities 4 Strategy, with total capital commitments of €4.1 billion across the commingled fund together with several separately managed accounts. 

Ares Management Corporation, a global alternative investment manager, has launched the Ares Strategic Income Fund, a perpetual capital, continuously offered, non-traded business development company, with around $1.5 billion in initial investable capital.

O2 Investment Partners, a private equity firm investing in growth-oriented, privately-held businesses in the North American lower middle market, has held the final closing of O2 Investment Partners Fund IV (Fund IV) with $445 million in capital commitments. 

Gilde Healthcare has raised €600 million in capital commitments for Gilde Healthcare Venture&Growth VI, a new investment fund which will focuse on fast growing companies developing solutions for better care at lower cost. 

Forbion, a European life sciences venture capital firm, has raised €1.35 billion ($1.5 billion) for its two newest funds, bringing the firm’s total funds under management to €3 billion. Both exceeded their original target sizes and represent Forbion’s largest fundraising to date. Both funds reached their hard caps of €750

Flexstone Partners has closed another vintage of its small- and middle-market private equity co-investment funds – Flexstone Partners’ Global Opportunities IV – with $790 million in capital commitments, despite “challenging global markets”. An affiliate of Natixis Investment Managers with over $10 billion assets under management (AUM), Flexstone Partners specialises in

Aquilius Investment Partners, a Singapore based investment manager focused on secondaries in the Asia Pacific region, has held the final closing of its maiden AIP Secondary Fund I, with over US$400 million in client commitments.